论文部分内容阅读
红白血病一向被认为是一种对化疗不敏感的急性非淋巴细胞性白血病。近年来,偶见一些改善化疗的个案报导。但对红白血病的化疗方案没有进行系统的研究。最近作者用红比霉素和强的松治疗红白血病,获得了较高的缓解率。作者共治疗9名红白血病,全部用红比霉素和强的松治疗。诊断时年龄为16岁至58岁,平均50岁。7例男性,2例女性。3例病人曾接受过多种药物治疗,1例接受过6-MP治疗。均未缓解。红白血病(Di Guglielmo′s Syndrome)是一种急性髓
Erythroleukemia has long been considered as an acute non-lymphocytic leukemia that is not chemosensitive. In recent years, occasionally some case reports of improving chemotherapy have been reported. However, there is no systematic study of erythroleukemia chemotherapy regimens. The authors recently used erythromycin and prednisone treatment of erythroleukemia, obtained a higher response rate. The authors treated a total of 9 patients with erythroleukemia, all with rubenomycin and prednisone treatment. The age of diagnosis at the age of 16 to 58 years, mean 50 years. 7 males and 2 females. Three patients had multiple drug treatments and one received 6-MP. Neither ease. Di Guglielmo’s Syndrome is an acute myeloid